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Nan-protein-bound iron (II~~I-iron), ; I potcnl prn~~sid;rrit, is ~xchcnt ill ~i c \ v l~(~~r i plasrn;~, and C; I I I iriducc pcroxicl;~rio~~ trf surl;rct:~l~t (hloist~ri ct :!I, I-;rliccl 1993;341:79). T l~i s stutly :rsscssccI tlrc pcrsis!cncc 11f 11p11-irilr1 ( I~l c o~l i y i .~~l c assay) i n 26 infants (GA; (26) (27) (28) (29) (30) (31) (32) (33) (34) r l i~~& was givcn 3 x 2.51 llJ;kgjweek s.c. from tI:ry 3 to dav 42 of life (17 single doses). Oral Iron rtartcd in both groups on day 14 wrtlr 2 In ')da .itid was ;ldjusted :~ccording to serum fcrritin ~eve~s. Results: I<c~iculocytc (~~f ; I n J l ; c u t r o~l l l i~ counta 635. The present study was undertaken to study the effect of oxygen exposure on lung hyaluronan concentration and lung water in rabbit pups born at term. Some pups were kcpt in oxygen and some wcre kcpt in air. I'ups were wcrificed and lungs were tnkcn at an age of 4-6 days. Tllc walcr coritenl was ~iiwsurcd as wclldry wclght, and Ihe l~yaluronan conccnlration witli a r;~dlolirctric assny kit ( [ [ A 50, I'lrar~~incla, Ul~p,nl;r).
R E C O M B I N A N T E R Y T I I R O P O I E T I N (rhEPO) R E D U C E S THE
Rcsulls: In tlic lungs from pups kept in oxygen significantly higlrcr hyaluronan concentrations were seen both at 4 (p<O.IXll;n= 14) arid 6 (p<O.OI;n= 17) d;rys o f age compared to the lungs from the pllps kept in air (n=15 and 29, respcc~ively). This was accompanied by a higher lung water conlcnt (p<0.001) than in pups kept in air a1 4 days o f age. Conclusion: I n tcrlii rabbit pups lung 11);1luron;rn co~iccntr;tt~on ;rnd lulig \v.itcr conlent IncrcJsc during oxygen expolure.
PERSISTENT PULMONARY IIYPERTCNSION OF TllE NEWBORN (PPHN) I S SELECTIVELY LOWERED DY PROSTACYCLIN ( P C ) . , M a r i a n w E r o n e n . M a i i a P o h i a v u o r i . E r k k l P e s o n e n . S t u r e A n d e r s s o n . K a r i 0 . R a i v i~. C h i l d r e n ' s H o s p i t a l a n d D e p a r tm e n t o f Ob/Gyn, U n i v e r s i t y o f H e l s i n k i , F i n l a n d .
PPHN i s a common i n d i c a t i o n f o r ECMO b e c a u s e o f s e v e r e h y p o x e m i a a n d m o r t a l i t y r i s k . We s t u d i e d t h e e f f e c t s o f PC
i n 0 i n f a n t s ( b . w t . 2 5 4 0 -4 1 3 0 g, q e s t . a g e 34-42 wk) w i t h r e s p i r a t o r y f a i l u r c a n d PPHN. A t mean a g e 19 ( r a n g e 3 -3 2 ) h , d e s p i t e m a x i m a l v e n t i l a t o r t h e r a p y a n d F i 0 2 o f 1 . 0 , mcan pa02/PA02 was 0.07 ( r a n g e 0 . 0 4 -0 . 1 0 ) a n d AaDO2 614 ( 5 2 1 -6 4 0 ) mmHg. Mean p u l m o n a r y a r t e r y p r e s s u r e (PAP) b y e c h o c a r d i og r a p h y was 68 ( 6 4 -8 0 ) a n d s y s t e -m i c p r e s s u r e (DP) 59 ( 5 1 -6 4 ) mmHg. A f t e r v o l u m e c o r r e c t i o n a n d d u r i n g d o p a m i n e i n f u s i o n , PC was i n c r e a s e d s t e p w i s e f r o m a mean o f 1 0 t o 55 (max. 1 2 0 ) n g / k g / m i n i n 4-12 h, a t w h i c h t i m e PAP h a d d e c r e a s e d t o 49 ( 4 5 -5 5 ) a n d DP t o 53 ( 4 2 -6 3 ) mmllg, PAP thereafter r e m a i n i n g b e l o w BP. A f t e r 7 2 h PAP was 50 ( 2 5 -8 6 ) , BP 6 6 (55-72), paO2/PA02 0.14 (0.08-0,40), a n d AaDO2 429 ( 8 3 -6 0 5 ) a t F i 0 2 o f 0 . 5 9 . A l l p a t i e n t s s u r v i v e d w i t h o u t ECMO, PC was s t o p p e d a t 5 . 3 ( 3 -1 0 . 5 ) d a n d v e n t i l a t o r t h e r a p y a t 7 . The effect of surfactants In treatment of neonalal RDS 1s well known However, the favourable results Increase the demand for neonalal lnteslve care We collected retrospectrvely cllnlcal and follow-up data of all 29 very low blrthwe~ght (VLBW) Infants who recelved surfactant In the OSlRlS study (from March 1991 to November 1991) and of 30 VLBW patlents born durtng the prevtous year who d~d not recelve surfactant treatment Pattents were eltg~ble lo the control group 11 they had at least once arlerlal/alveolar oxygen ratlo <O 22
The gestational age, blrlhwe~ght and blood pressure were s~m~lar In both groups Only 6 Infants In the control group survlved and only 2 of lhem d~d no1 have any neurolog~cal sequelae In the OSlRlS group 20 S~~l v e d 9 without neurolog~cal compllcallons The mean duratlon of neonatal lntenslve care was 10 2 days In the controll group and 26 8 days In the OSlRlS group The mean duratlon of neonatal lntenslve care of the survivors was 32 days In bolh groups A slm~lar effect was observed on the tlme on resprrator, and on the durabon of oxygen therapy and of hospltal care
The costs of neonatal lntenslve care were In 1992 about 1500 US$ and the cost for care on a paed~atrlc ward were about 400 US$ per day Thus glvlng a VLBW Infant surfactant will Increase the costs wllh al least 36 000 US$ The costs per survlvor were wlthout surfaclant about 3110 US$ and wlth surfactant 2730 US$ The costs per healthy suwlvor were 9330 US$ and 6670 US$, respecttvely Thls study Illustrates the econom~cal problems associated wtth lrnprovments of neonatal lntenslve care Although the prlce per survivor decreases the Increase of total costs IS very larqe The prlce of surfaclant ~tself IS almost neol~aible
